Shares in Puma Biotechnology jumped 40% after the FDA trod lightly around doubts about its filing for approval of breast cancer drug neratinib.

ViaCyte picked up $10 million to fund the clinical development of its stem cell-derived treatment for patients who have Type 1 diabetes and are at risk of…

Perennial biotech investor and backer Takeda has signed its latest collaboration with Nektar Therapeutics that will see the pair work on combo cancer…

Amgen and UCB's romosozumab trounced a comparator drug in a trial in osteoporosis, but there's a big catch: The therapy seems to cause side effects…

Shire and drug partner Xenetic have released new data for their collaborative bleeding disorder drug SHP656, and the news isn’t good.

Ablynx and Merck KGaA have moved their osteoarthritis candidate to the cusp of the clinic.

Neuroscientists at Brigham and Women's Hospital were searching for clues to the development of MS when they found an antibody with cancer-fighting…

La Jolla Pharmaceutical has posted a full look at data from a phase 3 trial of its vasodilatory shock candidate LJPC-501.

GI Dynamics announced Thursday that the CE mark for its EndoBarrier intestinal liner was suspended.